XML 116 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Millions
Total
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Previously Reported
Common Stock
Previously Reported
Paid-in Capital
Previously Reported
Retained Earnings
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Cumulative Effect of Adoption of New Accounting Standard
Cumulative Effect of Adoption of New Accounting Standard
Retained Earnings
Cumulative Effect of Adoption of New Accounting Standard
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Cumulative Effect of Adoption of New Accounting Standard                     $ 0.5 $ 0.5  
Beginning balance (in shares) at Dec. 31, 2016             51,300,000            
Beginning balance at Dec. 31, 2016           $ 1,975.2 $ 5.1 $ 660.3 $ 1,172.8 $ 137.0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net Income $ 120.9     $ 120.9                  
Other Comprehensive Income (Loss) (Note 13) 57.4       $ 57.4                
Cash Dividends and Dividend Equivalents to Shareholders $ (49.5)     (49.5)                  
Repurchases of Common Stock (in shares) 0                        
Equity-based Compensation Cost (Note 11) $ 9.4   $ 9.4                    
Equity-based Awards, Net of Shares Exchanged (Note 11) (in shares)   200,000                      
Equity-based Awards, Net of Shares Exchanged (Note 11) 1.7   3.4 (1.7)                  
Ending balance (in shares) at Dec. 31, 2017   51,500,000         51,500,000            
Ending balance at Dec. 31, 2017 2,115.6 $ 5.1 673.1 1,224.8 212.6 $ 2,115.6 $ 5.1 $ 673.1 $ 1,243.0 $ 194.4      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Cumulative Effect of Adoption of New Accounting Standard                     $ 0.0 $ (18.2) $ 18.2
Net Income 190.1     190.1                  
Other Comprehensive Income (Loss) (Note 13) (190.8)       (190.8)                
Cash Dividends and Dividend Equivalents to Shareholders $ (56.4)     (56.4)                  
Repurchases of Common Stock (in shares) 0                        
Equity-based Compensation Cost (Note 11) $ 18.6   18.6                    
Equity-based Awards, Net of Shares Exchanged (Note 11) (in shares)   100,000                      
Equity-based Awards, Net of Shares Exchanged (Note 11) (5.6) $ 0.0 (2.6) (3.0) 0.0                
Issuances of Common Stock (in shares)   13,100,000                      
Issuances of Common Stock 978.6 $ 1.4 977.2 0.0                  
Ending balance (in shares) at Dec. 31, 2018   64,700,000                      
Ending balance at Dec. 31, 2018 3,050.1 $ 6.5 1,666.3 1,355.5 21.8                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net Income 531.1     531.1                  
Other Comprehensive Income (Loss) (Note 13) 314.3       314.3                
Cash Dividends and Dividend Equivalents to Shareholders $ (68.4)     (68.4)                  
Repurchases of Common Stock (in shares) 0                        
Equity-based Compensation Cost (Note 11) $ 25.3   25.3                    
Equity-based Awards, Net of Shares Exchanged (Note 11) (in shares)   400,000                      
Equity-based Awards, Net of Shares Exchanged (Note 11) (9.2)   (1.3) (7.9)                  
Issuances of Common Stock (in shares)   1,600,000                      
Issuances of Common Stock 127.2 $ 0.2 127.0 0.0                  
Shares Issued Under Employee Stock Purchase Plan (Note 10) 1.9   1.9                    
Ending balance (in shares) at Dec. 31, 2019   66,700,000                      
Ending balance at Dec. 31, 2019 $ 3,972.3 $ 6.7 $ 1,819.2 $ 1,810.3 $ 336.1